Table 4.

Univariate Analysis of Prognostic Value of AML Patients

	CR		RFS		OS
	p	OR (95%C.I)	p	HR (95%C.I)	p	HR (95%C.I)
Age>60	0.921	1.050 (0.401–2.750)	0.9	1.044 (0.531–2.051)	0.661	1.184 (0.557–2.517)
WBC count	0.963	1.000 (0.993–1.008)	0.586	1.001 (0.996–1.006)	0.515	1.002 (0.996–1.007)
CR vs NCR			<0.001*	3.570 (1.957– 6.512)	0.003*	2.816 (1.439– 5.510)
NPM1	0.677	0.840 (0.370–1.908)	0.437	0.790 (0.436 – 1.433)	0.2	0.629 (0.310– 1.279)
FLT3/ITD	0.003*	3.667 (1.561–8.614)	0.021*	1.971 (1.109– 3.503)	0.008*	2.440 (1.262– 4.717)
lnRNA ANRIL	<0.001*	4.896 (2.044–11.728)	<0.001*	4.865 (2.465–9.600)	<0.001*	4.579 (2.084–10.062)
lnRNA SNHG14	<0.001*	6.000 (2.453–14.678)	<0.001*	5.682 (2.812–11.483)	<0.001*	4.646 (2.114–10.209)

HR, Hazard ratio; OR, Odd`s ratio; C.I, Confidence interval; LL, Lower limit; UL, Upper Limit; *, Statistically significant at p ≤ 0.05